Bristol, United Kingdom
Siloton, founded in 2020, is at the forefront of revolutionary advancements in the medical technology sector. With its industry-leading slogan, "The world's smallest optics for the world's largest health problems," the company is pioneering the development of miniaturised optical technology tailored for medical imaging.
Specialising in the production of quantum photonic chips and Optical Coherence Tomography (OCT), Siloton focuses on the early detection and ongoing monitoring of significant health conditions such as macular degeneration, glaucoma, diabetes, multiple sclerosis (MS), and certain types of cancer. This niche positions the company at the intersection of the Manufacturing and Medical Devices industries.
Headquartered in the United Kingdom, Siloton recently secured a $190.00K Seed Round investment on 01 December 2023, backed by South East Angels. This financial boost is set to further propel their innovative efforts in transforming healthcare diagnostics.
